Diarrhea and weight loss in common variable immunodeficiency;Häufiges symptom-seltene ursache: Diarrhö bei immundefizienzsyndrom

Zeitschrift fur Gastroenterologie

Volumn 42, Issue 7, 2004, Pages 599-603

  Liesch, Z ^a   Hanck, C ^a   Werth, B ^a   Kuhn, M ^a   Liesch, M ^a   Reinhart, W H ^a  

^a Fachbereich Gastroenterologie und Hepatologie   (Switzerland)

Author keywords

Campylobacter jejuni; Common variable immunodeficiency (CVID) syndrome; Lambliasis; Malabsorption

Indexed keywords

IMMUNOGLOBULIN;

ADULT; ARTICLE; BRONCHIECTASIS; CAMPYLOBACTER JEJUNI; CASE REPORT; COMMON VARIABLE IMMUNODEFICIENCY; DIARRHEA; GIARDIASIS; GRAM NEGATIVE INFECTION; HUMAN; IMMUNOTHERAPY; MALE; SPLENOMEGALY; WEIGHT REDUCTION;

ADULT; COMMON VARIABLE IMMUNODEFICIENCY; DIAGNOSIS, DIFFERENTIAL; DIARRHEA; ENDOSCOPY, GASTROINTESTINAL; HUMANS; IMMUNIZATION, PASSIVE; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; OPPORTUNISTIC INFECTIONS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 3343024287     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-813184     Document Type: Article

References (39)

1. WHO/OMS. Primary immunodeficiency diseases. Report of a WHO Scientific Group. Clin Exp Immunol 1997; 109 (Suppl 1): 1-28
2. Nonoyama S, Farrington M, Ishida H et al. Activated B cells from patients with common variable immunodeficiency proliferate and synthesize immunoglobulin. J Clin Invest 1993; 92: 1282-1287
3. Sicherer SH, Winkelstein JA. Primary immunodeficiency diseases in adults. JAMA 1998; 279: 58-61
4. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: Clinical and immunological features of 248 patients. Clin Immunol 1999; 92: 38-48
5. Hausser C, Virelizier JL, Buriot D et al. Common variable hypogammaglobulinemia in children. Clinical and immunological observations in 30 patients. Am J Dis Child 1983; 137: 833-837
6. Thon V, Eggenbauer H, Wolf HM et al. Antigen presentation by common variable immunodeficiency (CVID) B cells and monocytes is unimpaired. Clin Exp Immunol 1997; 108: 1-8
7. Agematsu K, Futatani T, Hokibara S et al. Absence of memory B cells in patients with common variable immunodeficiency. Clin Immunol 2002; 103: 34-42
8. Braig DU, Schaffer AA, Glocker E et al. Linkage of autosomal dominant common variable immunodeficiency to chromosome 5 p and evidence for locus heterogeneity. Hum Genet 2003; 112: 369-378
9. Rosen FS, Cooper MD, Wedgwood RJ. The primary immunodeficiencies. N Engl J Med 1984; 311: 235-242
10. Cambronero R, Carrock Sewell WA et al. Up-regulation of IL-12 in monocytes: A fundamental defect in common variable immunodeficiency. J Immunol 2000; 164: 488-494
11. Volanakis JE, Zhu ZB, Schaffer FM et al. Major histocompatibility complex class III genes and susceptibility to immunoglobulin A deficiency and common variable immunodeficiency. J Clin Invest 1992; 89: 1914-1922
12. Nijenhuis T, Klasen I, Weemaes CM et al. Common variable immunodeficiency (CVID) in a family: an autosomal dominant mode of inheritance. Neth J Med 2001; 59: 134-139
13. Ryser O, Morell A, Hitzig WH. Primary immunodeficiencies in Switzerland: first report of the national registry in adults and children. J Clin Immunol 1988; 8: 479-485
14. Stray-Pedersen A, Abrahamsen TG et al. Primary immunodeficiency diseases in Norway. J Clin Immunol 2000; 20: 477-485
15. Al-Attas RA, Rahi AH. Primary antibody deficiency in Arabs: first report from eastern Saudi Arabia. J Clin Immunol 1998; 18: 368-371
16. Matamoros Flori N, Llambi Mila J, Espanol Boren T et al. Primary immunodeficiency syndrome in Spain: First report of the national registry in children and adults. J Clin Immunol 1997; 17: 333-339
17. Pfluger H, Helbling A, Mordasini C et al. CVID (common variable immunodeficiency): Heterogene Krankheitsmanifestation dieses häufigsten symptomatischen primären Immundefektes. Schweiz Med Wochenschr 2000; 130: 1590-1599
18. Cambronero R, Sewell WA, North ME et al. Up-regulation of IL-12 in monocytes: a fundamental defect in common variable immunodeficiency. J Immunol 2000; 164: 488-494
19. Cunningham-Rundles C, Bodian C, Ochs HD et al. Long-term low-dose IL-2 enhances immune function in common variable immunodeficiency. Clin Immunol 2001; 100: 181-190
20. McQuaid A, Tormey VJ, Trafford B et al. Evidence for increased expression of regulatory cytokine receptors interleukin-12R and interleukin 18R in common variable immunodeficiency. Clin Exp Immunol 2003; 134: 321-327
21. Tickett KM, Kumararatne DS, Banerjee AK et al. Common variable immunodeficiency: respiratory manifestations, pulmonary function and high-resolution CT scan findings. QJM 2002; 95: 655-662
22. Washington K, Stenzel T, Buckley R et al. Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia. Am J Surg Pathol 1996; 20: 1240-1252
23. Sneller MC, Strober W, Eisenstein EM et al. New insight into common variable immunodeficiency. Ann Int Med 1993; 118: 720-730
24. Luzi G, Zullo A, Iebba F et al. Duodenal pathology and clinical-immunological implications in common variable immunodeficiency patients. Am J Gastoenterol 2003; 98: 118-121
25. Teahon K, Webster AB, Price AB et al. Studies on the enteropathy associated with primary hypogammaglobulinaemia. Gut 1994; 35: 1244-1249
26. De Weerth A, Gocht A, Seewald S et al. Duodenal nodular lymphoid hyperplasia caused by giardiasis infection in a patient who is immunodeficient. Gastrointest Endosc 2002; 55: 605-607
27. Zamir A, Parasher G, Moukarzel AA et al. Immunoproliferative small intestinal disease in a 16 year old boy presenting as severe malabsorption with excellent response to tetracycline treatment. J Clin Gastroenterol 1998; 27: 85-89
28. Busse PJ, Razvi S, Cunningham-Rundles C. Efficacy of intravenous immunglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J Allergy Clin Immunol 2002; 109: 1001-1004
29. Pirofski B. Intravenous immune globulin therapy in hypogammaglobulinemia. A review. Am J Med 1984; 76: 53-60
30. Quinti I, Pierdominici M, Marziali M et al. European Study Group for the Surveillance of Immunoglobulin Safety. European surveillance of immunoglobulin safety - results of initial survey of 1243 patients with primary immunodeficiencies in 16 countries. Clin Immunol 2002; 104: 231-236
31. Eijkhout HW, van Der Meer JW, Kallenberg CG et al. The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial. Ann Intern Med 2001; 135: 165-174
32. Liese JG, Wintergerst U, Tympner KD et al. High vs. low-dose immunoglobulin therapy in the long-term treatment of X-linked agammaglobulinemia. Am J Dis Child 1992; 146: 335-339
33. Wahn V. Einsatz von Immunglobulinen bei angeborenen und erworbenen Immundefekten. In: Wahn V (Hrsg). Klinischer Einsatz von intravenösen Immunglobulinen. Bremen, London, Boston: Unimed-Verlag, 2000: 55-60
34. Libanore M, Bicocchi R, Rossi MR et al. Incidence of giardiasis in adult patients with acute enteritis. Minerva Med 1991; 82: 375-380
35. Herbst EW, Armbruster M, Rump JA et al. Intestinal B cell defects in common variable immunodeficiency. Clin Exp Immunol 1994; 95: 215-221
36. Gardner TB, Hill DR. Treatment of giardiasis. Clin Microbiol Rev 2001; 14: 114-128
37. Banerjee S, La Mont JT. Treatment of gastrointestinal infections. Gastroenterology 2000; 118: 48-67
38. Blaser MJ. Epidemiologic and clinical features of campylobacter jejuni infections. J Inf Dis 1997; 176: 103-105
39. Hood AM, Pearson AD, Shahamat M. The extent of surface contamination of retailed chickens with Campylobacter jejuni serogroups. Epidemiol Infect 1988; 100: 17-25